ישראל - עברית - Ministry of Health

teva medical ltd - glucose monohydrate - תמיסה לאינפוזיה - glucose monohydrate 50 % - glucose - glucose - dextrose 50 % injection is indicated as a caloric component in a parenteral nutrition regimen. it is used with an appropriate protein (nitrogen) source in the prevention of nitrogen loss or in the treatment of negative nitrogen balance in patients where: 1) the alimentary tract cannot/should not be used 2) gastrointestinal absorption of protein is impaired or 3) metabolic requirements for protein are substantially increased , as with extensive burns.

ישראל - עברית - Ministry of Health

סלנגו-קריסטליין בעמ - מסייע להגנה על העור בפני צריבות מדוזות, מגן על העור מפני קרני השמש פי 50 מההגנה

ישראל - עברית - Ministry of Health

נאוטק קבוצת קורדן בעמ - קרם הגנה spf 50 uva/uvbהיפואלרגני

ישראל - עברית - Ministry of Health

נאוטק קבוצת קורדן בעמ - קרם הגנה spf 50 uva/uvbהיפואלרגני

ישראל - עברית - Ministry of Health

נאוטק קבוצת קורדן בעמ - קרם להגנה מקרני השמש

ישראל - עברית - Ministry of Health

נאוטק קבוצת קורדן בעמ - ףוגל/םינפל, ןווג / ליגר fps-05 שמשהמ הנגה םרק

ישראל - עברית - Ministry of Health

novo nordisk ltd., israel - insulin aspart - תרחיף להזרקה - insulin aspart 100 u/ml - insulin aspart - insulin aspart - treatment of diabetes mellitus.

ישראל - עברית - Ministry of Health

cts chemical industries ltd, israel - losartan potassium - טבליה - losartan potassium 50 mg - losartan - losartan - hypertension: losartan indicated for the treatment of heart failure ( nyha ii and iii) usually in addition to diuretics and/or digitalis if use of an ace inhibitor is not appropriate.switching patients with heart failure who are stable on an ace inhibitor to losartan is not recommended. renal protection in type - 2 diabetic patients with proteinuria: losartan indicated to delay the progression of renal disease as measured by a reduction in the combined incidence of doubling of serum creatinine end stage renal disease ( need for dialysis or renal transplantation) or death and to reduce proteinuria.reduction in the risk of cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrphy. losartan is indicated to reduce the risk of cardiovascular morbidity and mortality as measured by the combined incidence of cardiovascular death stroke and myocardial infarction in hypertensive patients with left ventricular hypertrophy. the benefit of losartan on the primary composite end point

ישראל - עברית - Ministry of Health

cts ltd - testosterone - ג'ל - testosterone 0.05 mg/sachet - testosterone - testosterone - testosterone replacement therapy for male hypogonadism when testosterone deficiency has been confirmed by clinical features and biochemical tests.

ישראל - עברית - Ministry of Health

bayer israel ltd - cyproterone acetate - טבליה - cyproterone acetate 50 mg - cyproterone - cyproterone - for antiandrogen therapy in men: sexual disorders, inoperable prostatic carcinoma.